KCNIP3 and systemic sclerosis: Taken together, these results highlight a previously unrecognized mechanistic link between the A20-DREAM regulatory network and fibrotic disease manifestations of SSc and demonstrate a novel cell-autonomous regulatory role of A20 in mesenchymal cells that is distinct from its well-documented function in conventional immune cells.